Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | HCID 67236171 | — |
| Reactant | HCID 67241539 | HCID 67241539 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 67239791 | HCID 67239791 | 55.6% |
Reaction Steps
To a solution of 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (preparation described in Intermediate XIX (1), 59 mg, 0.253 mmol), 4-(5-bromo-4-chloro-1,3-thiazol-2-yl)-1,4-diazepan-2-one (75 mg, 0.241 mmol), 1,1′-bis(diphenylphosphino)ferrocene-palladium(II)dichloride (35 mg, 0.048 mmol) in dioxane (0.600 mL) was added 2M aqueous sodium carbonate (0.240 mL, 0.480 mmol). The mixture was heated on a reaction block at 100° C. for 3 hours, and subsequently cooled to room temperature. The dark mixture was filtered through a celite plug, which was rinsed with 10% isopropanol in CHCl3. The eluent was concentrated and purified by preparative HPLC Normal phase, eluting with CH2Cl2/MeOH (0-30%). The 3rd peak was collected and concentrated to give 4-[5-(3-amino-5-methylphenyl)-4-chloro-1,3-thiazol-2-yl]-1,4-diazepan-2-one (45 mg, 0.134 mmol, 29.1% yield) as a brown solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08735417B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-1d1366f89c964d96869d8758ec68ee03 |
|---|
| Source note | uspto-grants-2014_05 |
|---|